Clinical Recommendations of the Northwest Society for Enteral and Parenteral Nutrition, Interregional Association for Emergency Surgery, Russian Gastroenterological Association, Union of Rehabilitation Therapists of Russia and Russian Transplantation Society on Diagnosis and Treatment of Short Bowel Syndrome-Associated Intestinal Failure in Adults

Aim. Current clinical recommendations address the epidemiology, causes, clinical manifestations and pathogenesis of possible immediate and long-term complications, as well as the problematic issues related to treatment and rehabilitation of adult short bowel syndrome patients.

Key points. Short bowel syndrome (SBS) is a symptom complex of impaired digestion caused by the reduction of small intestine absorptive surface and manifested by intestinal failure (IF) of various severity (maldigestion and malabsorption) developing into malnutrition and systemic somatogenic disorders. The vital strategic aspects of its treatment are the personalisation of liquid, macro- and micronutrients consumption as well as avoidance of intestinal failure- and parenteral nutrition-associated complications. Various nutritional support regimes and the indications for infusion therapy and maintenance parenteral nutrition are considered in this patient category, also in outpatient settings. To mitigate the dependence on intravenous fluid- and nutrient administration and attain enteral autonomy in SBS-IF patients, the use of recombinant glucagon-like peptide-2 (GLP-2) is justified as exerting a pronounced trophic effect on the epithelial regenerative potential as well as structural and functional adaptation of intestinal mucosa. The SBS-IF patients prescribed with home parenteral nutrition and/or their caregivers should be trained in a special programme that covers the catheter care, preparation of infusion solutions and nutrient mixture container, infusion pump operation as well as the prevention, recognition and management of complications. The main referral indications for small bowel transplantation (SBT) are: fast-progressing cholestatic liver disease-complicated irreversible intestinal failure; thrombosis of two or more central venous conduits used for parenteral nutrition; recurrent catheter-associated bloodstream infection.

Conclusion. Current recommendations on diagnosis and treatment as well as the developed criteria of medical aid quality assessment are applicable at different levels of healthcare.

1. Sobotka L. (ed.) Basics in clinical nutrition. 4th ed. Tr. from English. Moscow: MedExpertPress, 2015 (In Russ.).

2. Buchman A.L., Scolapio J., Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124(4):1111—34. DOI: 10.1016/s0016-5085(03)70064-x

3. Mughal M., Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet. 1986;2:383-7. DOI: 10.1016/s0140-6736(86)90065-6

4. Van Gossum A., Bakker H., Bozzetti F., Leon-Sanz M., Hebuterne X., Pertkiewicz M., et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN — Home Artificial Nutrition Working Group. Clin Nutr. 1999;18(3):135-40. DOI: 10.1054/clnu.1999.0021

5. Juana-Roa J., Wanden-Berghe C., Sanz-Valero J. The reality of homebased parenteral nutrition in Spain. Nutr Hosp. 2011;26(2):364-8. DOI: 10.1590/S0212-16112011000200018

6. Jeppesen P.B. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012;5(3):159-71. DOI: 10.1177/1756283X11436318

7. Brandt C.F., Bangsgaard L., Jess T., Staun M. The evolution of treatment of patients with intestinal failure with home parenteral nutrition. Gastroenterology. 2012;142(5):613-4. DOI: 10.1016/S0016-5085(12)62359-2

8. Saltanov A.I., Popova T.S., Khubutiya M.Sh. Enteral and parenteral nutrition: national guidelines. Moscow: GEOTAR-Media; 2014 (In Russ.).

9. Safioleas M., Stamatakos M., Safioleas P., Diab A., Karanikola E., Safioleas C. Short bowel syndrome: amelioration of diarrhea after vagotomy and pyloroplasty for peptic hemorrhage. Tohoku J Exp Med. 2008;214(1):7-10. DOI: 10.1620/tjem.214.7

10. Thompson J.S., DiBaise J.K., Iyer K.R., Yeats M., Sudan D.L. Postoperative short bowel syndrome. J Am Coll Surg. 2005;201(1):85-9. DOI: 10.1016/j.jamcoll-surg.2005.02.034

11. Donohoe C.L., Reynolds J.V. Short bowel syndrome. Surgeon. 2010;8(5):270-9. DOI: 10.1016/j.surge.2010.06.004

12. Pironi L., Hebuterne X., Van Gossum A., Messing B., Lyszkowska M., Colomb V., et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol. 2006;101(7):1633—43. DOI: 10.1111/j.1572-0241.2006.00710.x

13. Amiot A., Messing B., Corcos O., Panis Y., Joly F. Determinants of home parenteral nutrition dependence and survival of 268 patients with nonmalignant short bowel syndrome. Clin Nutr. 2013;32(3):368-74. DOI: 10.1016/j.clnu.2012.08.007

14. Jeppesen P.B. Spectrum of Short Bowel Syndrome in Adults: Intestinal Insufficiency to Intestinal Failure. JPEN J Parenter Enteral Nutr. 2014;38(1):8—13. DOI: 10.1177/0148607114520994

15. Carbonnel F., Cosnes J., Chevret S., Beaugerie L., Ngo Y., Malafosse M., et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr. 1996;20(4):275—80. DOI: 10.1177/0148607196020004275

16. Baranskaya E.K., Shulpekova Yu.O. Principles of management of patients with short bowel syndrome. Russian medical journal. 2010;18(13):789-94 (In Russ.).

17. Nightingale J., Woodward J.M.; Small Bowel and Nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel. Gut. 2006;55 Suppl 4(Suppl 4):iv1—12. DOI: 10.1136/gut.2006.091108

18. Shaffer J. Intestinal failure: definition and service development. Clin Nutr. 2002;21:144-7.

19. Thompson J.S., Weseman R., Rochling F., Grant W., Botha J., Mercer D.F. Pre-resection BMI influences post resection BMI in short bowel syndrome. XI International Small Bowel Transplant Symposium; 2009; Bologna, Italy: Medimond International Proceedings. 2009;103-9.

20. Thompson J.S., Weseman R., Rochling F.A., Mercer D.F. Current management of short bowel syndrome. Curr Probl Surg. 2012;49(2):52-115. DOI: 10.1067/j.cp-surg.2011.10.002

21. Szczgiel B., Jonkers-Schuitema C., Naber T. Basics in Clinical Nutrition: Nutritonal support in extensive gut resections (short bowel). Eur e-J Clin Nutr Metab. 2010;5(1):63-8. DOI: 10.1016/j.eclnm.2009.06.021

22. Kelly D.G., Tappenden K.A., Winkler M.F. Short bowel syndrome: highlights of patient management, quality of life, and survival. JPEN J Parenter Enteral Nutr. 2014;38(4):427-37. DOI: 10.1177/0148607113512678

23. Scolapio J.S. Short bowel syndrome. JPEN J Parenter Enteral Nutr. 2002;26(5):11-6. DOI: 10.1177/014860710202600506

24. Nandivada P., Fell G.L., Gura K.M., Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016;103(2):629-34. DOI: 10.3945/ajcn.114.103986

25. Wales P.W., Allen N., Worthington P., George D., Compher C. American Society for Parenteral and Enteral Nutrition. Teitelbaum D. ASPEN clinical guidelines: Support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. JPEN J Parenter Enter Nutr. 2014;38(5):538-57. DOI: 10.1177/0148607114527772

26. Kapoor V., Malviya M.N., Soul R. Lipid emulsion for parenterally fed term and late preterm infants. Cochrane Database Syst Rev. 2019;6(6):CD013171. DOI: 10.1002/14651858.CD013171.pub2

27. Caldarini M.I., Pons S., D'Agostino D., Greco G., Negri G., Ascione A., et al. Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production. Dig Dis Sci. 1996;41(8):1649-52. DOI: 10.1007/BF02087915

28. Luft V.M. Clinical Nutrition Guide. St. Petersburg: Art-Express; 2016 (In Russ.).

29. Solomentseva T.A. Short bowel syndrome: tactics of a gastroenterologist. Acute and urgent conditions in the practice of a doctor. 2009;5:50-5 (In Russ.).

30. Gennari F.J., Weise W.J. Acid-base disturbances in gastrointestinal disease. Clin J Am Soc Nephrol. 2008;3(6):1861-8. DOI: 10.2215/CJN.02450508

31. DuPont A.W., Sellin J.H. Ileostomy diarrhea. Curr Treat Options Gastroenterol. 2006;9(1):39-48. DOI: 10.1007/s11938-006-0022-7

32. Sriram K., Lonchyna V.A. Micronutrient supplementation in adult nutrition therapy: practical considerations. JPEN J Parenter Enteral Nutr. 2009;33(5):548-62. DOI: 10.1177/0148607108328470

33. Pironi L., Arends J., Bozzetti F., Cuerda C., Gillanders L. , Jeppesen P.B., et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247-307. DOI: 10.1016/j.clnu.2016.01.020. Erratum in: Clin Nutr. 2017;36(2):619.

34. Gabe S.M., Shaffer J.L., Forbes A., Holst M., Irtun O., Klek S., et al. The management of patients with high output enterocutaneous gastrointestinal fistulae: a European Survey. Clin Nutr. 2012;7(1, Suppl):14-5. DOI: 10.1016/S1744-1161(12)70034-0

35. Staun M., Pironi L., Bozzetti F., Baxter J., Forbes A., Joly F., et al. ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients. Clin Nutr. 2009;28(4):467-79. DOI: 10.1016/j.clnu.2009.04.001

36. Heyland D.K. Enteral and parenteral nutrition in the seriously ill, hospitalized patient: a critical review of the evidence. J Nutr Helth Aging. 2000;4(1):31-41.

37. Eckerwall G., Andersson R. Early enteral nutrition in severe acute pancreatitis. Scand J Gastroenteral. 2001;36(5):449-57. DOI: 10.1080/003655201750153179

38. Definition of geriatrics. https://uemsgeriatricmedicine.org/www/land/definition/english.asp

39. Weimann A., Braga M., Carli F., Higashiguchi T., Hubner M., Klek S., et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017;36(6):623-50. DOI: 10.1016/j.clnu.2017.02.013

40. Chen S., Xia Y., Zhu G., Yan J., Tan C., Deng B., et al. Glutamine supplementation improves intestinal cell proliferation and stem cell differentiation in weanling mice. Food Nutr Res. 2018;62. DOI: 10.29219/fnr.v62.1439

41. Zhong X., Zhang X.H., Li X.M., Zhou Y.M., Li W., Huang X.X., et al. Intestinal growth and morphology is associated with the increase in heat shock protein 70 expression in weaning piglets through supplementation with glutamine. J Anim Sci. 2011;89(11):3634-42. DOI: 10.2527/jas.2010-3751

42. Ding L.A., Li J.S. Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia. World J Gastroenterol. 2003;9(6):1327-32. DOI: 10.3748/wjg.v9.i6.1327

43. Mingxiao G.U.O., Yousheng L.I., Jieshou L.I. Effect of growth hormone, glutamine, and enteral nutrition on intestinal adaptation in patients with short bowel syndrome. Turk J Gastroenterol 2013;24(6):463-8. DOI: 10.4318/tjg.2013.0555

44. Scolapio J.S., McGreevy K., Tennyson G.S., Burnett O.L. Effect of glutamine in short-bowel syndrome. Clin Nutr. 2001;20(4):319-23. DOI: 10.1054/clnu.2001.0433

45. Луфт В.М. Справочник по клиническому питанию. СПб.: Росбалт; 2018. [Luft V.M. Handbook of Clinical Nutrition. St. Petersburg: Rosbalt; 2018 (In Russ.)].

46. McIntyre P.B., Fitchew M., Lennard Jones J.E. Patients with a high jejunostomydo not need a special diet. Gastroenterology. 1986;91(1):25-33. DOI: 10.1016/0016-5085(86)90434-8

47. Levy E., Frileux P., Sandrucci S., Ollivier J.M., Masini J.P., Cosnes J., et al. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg. 1988;75(6):549-53. DOI: 10.1002/bjs.1800750615

48. Luft V.M., Bagnenko S.F., Shcherbuk Yu.A., Luft A.V. Enteral nutrition of patients in intensive care. St. Petersburg: ART-XPRESS; 2010 (In Russ.).

49. Nightingale J.M., Kamm M.A., van der Sijp J.R., Ghatei M.A., Bloom S.R., Lennard Jones J.E. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the ‘colonic brake' to gastric emptying. Gut. 1996;39(2):267-72. DOI: 10.1136/gut.39.2.267

50. Cosnes J., Evard D., Beaugerie L., Gendre J.P., Le Quintrec Y. Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. Nutrition 1992;8(6):406-11.

51. Joly F., Dray X., Corcos O., Barbot L., Kapel N., Messing B. Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology. 2009;136(3):824-31. DOI: 10.1053/j.gastro.2008.10.084

52. Forbes A. Challenges in treating intestinal failure and short bowel syndrome. https://lllnutrition.com/mod_lll/TOPIC12/old_version/m122.htm

53. Zaidel O., Lin H.C. Uninvited Guests: The Impact of Small Intestinal Bacterial Overgrowth on Nutritional Status. Practical Gastroenterology. 2003;27-34. https://med.virginia.edu/ginutrition/wp-content/uploads/sites/199/2015/11/zaidelarticle-July-03.pdf

54. Nordgaard I., Hansen B.S., Mortensen P.B. Colon as a digestive organ in patients with short bowel. Lancet. 1994;343:373-6. DOI: 10.1016/s0140-6736(94)91220-3

55. Lembo A., Zakko S.F., Ferreira N.L., Ringel Y. Rifaximin for the treatment of diarrhea associated irritable bowel syndrome: short term treatment leading to long term sustained response. Gastroenterology. 2008;134(4):545. DOI: 10.1016/S0016-5085(08)62544-5

56. Pimentel M., Lembo A., Chey W.D., Zakko S., Ringel Y., Yu J., et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22-32. DOI: 10.1056/NEJMoa1004409

57. Parfenov A.I. Enterology. Moscow: Medicinskoe informacionnoe agentstvo; 2008 (In Russ.).

58. Vanner S. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: Implications for treatment. Gut. 2008;57(9):1315-21. DOI: 10.1136/gut.2007.133629

59. Avdeev V. Diagnosis and treatment of bacterial overgrowth syndrome in the small intestine. Vrach. 2010;12:1-3 (In Russ.).

60. Maev I.V., Ivashkina I.Yu., Kucheryavy Yu.A., Oganesyan T.S. Diagnosis and treatment of bacterial overgrowth syndrome in the small intestine. Experimental and Clinical Gastroenterology. 2011;3:125-9 (In Russ.).

61. Wang B., Wu G., Zhou Z., Dai Z., Sun Y., Ji Y. et al. Glutamine and intestinal barrier function. Amino Acids. 2015;47(10):2143-54. DOI: 10.1007/s00726-014-1773-4

62. Gabrielli M., Angelo G.D., Rienzo T.D.I., Scarpellini E., Ojetti V. Diagnosis of small intestinal bacterial оvergrowth in the clinical practice. Eur Rev Med Pharmacol Sci. 2013;17(2; Suppl):30-5.

63. Bondarenko V.M., Matsulevich T.V. Intestinal dysbacteriosis as a clinical and laboratory syndrome: the current state of the problem. Guide for doctors. M.: GEOTAR-Media; 2007 (In Russ.).

64. Ardatskaya M.D. Bacterial Overgrowth Syndrome. Moscow: Forte Print; 2011 (In Russ.).

65. Plotnikova E.Yu., Borshch M.V., Krasnova M.V., Baranova E.N. Some aspects of diagnosis and treatment of excessive bacterial contamination of the small intestine in clinical practice. Lechashchiy vrach. 2013;2:40-4 (In Russ.).

66. Nightingale J.M.D., Lennard-Jones J.E., Walker E.R., Farthing M.J. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution and glucose polymer electrolyte solution (Maxijul). Gut. 1992;33(6):759-61. DOI: 10.1136/gut.33.6.759

67. Nightingale J.M.D. The short bowel. In: Nightingale J.M.D., ed. Intestinal Failure. London, UK: Greenwich Medical Media; 2001.

68. Parrish Q.R. The Clinician's Guide to Short Bowel Syndrome. Practical Gastroenterology. 2005;67-106. https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.477.3639&rep=rep1&type=pdf

69. Jeppesen P.B., Hoy C.E., Mortensen P.B. Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption. Am J Clin Nutr. 1999;70(1):78-84. DOI: 10.1093/ajcn/70.1.78

70. Kunz A.N., Noel J.M., Fairchok M.P. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004;38(4):457e8. DOI: 10.1097/00005176-200404000-00017

71. De Groote M.A., Frank D.N., Dowell E., Glode M.P., Pace N.R. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005;24(3):278-80. DOI: 10.1097/01.inf.0000154588.79356.e6

72. Maevskaya E.A., Cheryomushkin S.V., Krivoborodova N.A., Kucheryavyi Yu.A. Bacterial overgrowth syndrome in the small intestine: from recent scientific data to routine practice. Clinical Perspectives Gastroenterol Hepatol. 2015;5:29-40 (In Russ.).

73. Quigley E.M.M., Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil. 2007;19(3):166-72. DOI: 10.1111/j.1365-2982.2006.00879.x

74. Ardatskaya M.D., Loginov V.A., Minushkin O.N. New possibilities for diagnosing and correcting microecological disorders of the intestine. Consilium medicum. Gastroenterology. 2013;2:51-8 (In Russ.).

75. Uchida H., Yamamoto H., Kisaki Y., Fujino J., Ishimaru Y., Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg Actions. 2004;39(4):634-6. DOI: 10.1016/j.jped-surg.2003.12.026

76. Reddy V.S., Patole S.K., Rao S. Role of probiotics in short bowel syndrome in infants and children: systematic review. Nutrients. 2013;5(3):679-99. DOI: 10.3390/nu5030679

77. Shenderov B.A. Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis. 2013;24:203-99. DOI: 10.3402/mehd.v24i0.20399

78. Jeppesen P.B., Christensen M.S., Hoy C.E., Mortensen P.C. Essential fatty acid deficiency in patients with severe fat malabsorption. Am J Clin Nutr. 1997;65(3):837-43. DOI: 10.1093/ajcn/65.3.837

79. Leiderman I.N., Yaroshetsky A.I., Kokarev E.A., Mazurok V.A. Parenteral nutrition. Questions and answers. Guide for doctors. St. Petersburg: Only Press; 2016 (In Russ.).

80. Pironi L., Arends J., Baxter J., Bozzetti F., Pelaez R.B., Cuerda C., et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171-80. DOI: 10.1016/j.clnu.2014.08.017

81. Crenn P., Coudray-Lucas C., Thuillier F., Cynober L., Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000;119(6):1496-505. DOI: 10.1053/gast.2000.20227

82. Pironi L., Joly F., Forbes A., Colomb V., Lyszkows-ka M., Baxter J., et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011;60(1):17-25. DOI: 10.1136/gut.2010.223255

83. Barnadas G. Navigating home care: parenteral nutrition — part two. Pract Gastroenterol. 2003;27:13-30.

84. Kelly D.G. The clinician's responsibility for the consumer's financial wellbeing. Nutr Clin Pract. 2006;21(6):539-41. DOI: 10.1177/0115426506021006539

85. Mascioli E.A., Lopes S.M., Champagne C., Driscoll D.F. Essential fatty acid deficiency and home total parenteral nutrition patients. Nutrition. 1996;12(4):245-9. DOI: 10.1016/s0899-9007(96)90850-3

86. Jeppesen P.B., Hoy C.E., Mortensen P.B. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr. 2000;54(8):632-42. DOI: 10.1038/sj.ejcn.1601067

87. Dizdar O.S., Baspinar O., Kocer D., Dursun Z.B., Avci D., Karakukcu C., et al. Nutritional Risk, Micronutrient Status and Clinical Outcomes: A Prospective Observational Study in an Infectious Disease Clinic. Nutrients. 2016;8(3):124. DOI: 10.3390/nu8030124

88. Quigley E.M., Quera R., Abu-Shanab A. The Enteric Flora in Intestinal Failure: Small Intestinal Bacterial Overgrowth and Gut-Derived Sepsis. Malden: Blackwell Publishing; 2009.

89. Novak F., Heyland D.K., Avenell A., Drover J.W., Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002;30(9):2022-9. DOI: 10.1097/00003246-200209000-00011

90. Fusaro F., Hermans D., Wanty C., Veyckemans F., Pirenne J., Reding R. Post-serial transverse enteroplasty bowel redilatation treated by longitudinal intestinal lengthening and tailoring procedure. J Pediatr Surg. 2012;47(10):e19-22. DOI: 10.1016/j.jped-surg.2012.05.023

91. Culkin A., Gabe S., Bjarnason I., Grimble G., Madden A.M., Forbes A. A double-blind, randomized, controlled crossover trial of glutamine supplementation in home parenteral nutrition. Eur J Clin Nutr. 2008;62(5):575-83. DOI: 10.1038/sj.ejcn.1602754

92. Helmrath M.A., Fong J.J., Dekaney C.M.,Henning S.J. Rapid expansion of intestinal secretory lineages following amassive small bowel resection in mice. Am J Physiol Gastrointest Liver Physiol. 2007;292(1):215-22. DOI: 10.1152/ajpgi.00188.2006

93. D'Antiga L., Goulet O. Intestinal failure in children: The European view. J Pediatr Gastroenterol Nutr. 2013;56(2):118-26. DOI: 10.1097/MPG.0b013e318268a9e3

94. Kapoor V., Malviya M.N., Soul R. Lipid emulsion for parenterally fed term and late preterm infants. Cochrane Database Syst Rev. 2019;6(6):CD013171. DOI: 10.1002/14651858.CD013171.pub2

95. Jeppesen P.B., Lund P., Gottschalck I.B., Nielsen H.B., Holst J.J., Mortensen J., et al. Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life. Gastroenterol Res Pract. 2009;2009:425759. DOI: 10.1155/2009/425759

96. Jeppesen P.B., Sanguinetti E.L., Buchman A., Howard L., Scolapio J.S., Ziegler T.R., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54(9):1224-31. DOI: 10.1136/gut.2004.061440

97. Jeppesen P.B., Pertkiewicz M., Forbes A., Pironi L., GabeS.M., Joly F., et al. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide — analyses from a randomised, placebo-controlled study. Clin Nutr. 2013;32(5):713-21. DOI: 10.1016/j.clnu.2013.03.016

98. Carbonnel F., Cosnes J., Chevret S., Beaugerie L., Ngo Y., Malafosse M., et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr. 1996;20:275-80. DOI: 10.1152/ajpgi.00188.2006

99. Iyer K., Fujioka K., Boullata J.I., Zeigler T.R., Yuoseff N.N., Seidner D.L. Long-Term Safety and Efficacy with Teduglutide Treatment in Patients with Intestinal Failure Associated with Short Bowel Syndrome (SBS-IF): The Steps-3 Study. Clin Nutr. 2014;33:S167-8 DOI: 10.1016/S0261-5614(14)50437-2

100. Schwartz L.K., O'Keefe S.J., Fujioka K., Gabe S.M., Lamprecht G., Pape U.F., et al. Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. Clin Transl Gastroenterol. 2016;7(2):e142. DOI: 10.1038/ctg.2015.69

101. Byrne T.A., Wilmore D.W., IyerK., DibaiseJ., Clancy K., Robinson M.K., et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome:a prospective, randomized, placebo-controlled, double-blindclinical trial. Ann Surg. 2005;242(5):655-61. DOI: 10.1097/01.sla.0000186479.53295.14

102. Chen Y., Tai Y.H., Tseng B.J., Tseng S.H. Influence of Growth Hormone and Glutamine on Intestinal Stem Cells: A Narrative Review. Nutrients. 2019;11(8):1941. DOI: 10.3390/nu11081941

103. Shanbhogue L.K., Molenaar J.C. Short bowel syndrome: metabolic and surgical management. Br J Surg. 1994;81(4):486-99. DOI: 10.1002/bjs.1800810404

104. Thompson J.S. Surgery for patients with a short bowel. In: Nightingale J.M.D., eds. Intestinal failure. Greenwich: Greenwich Medical Media Limited. 2001:515-27.

105. Howard L., Claunch C., McDowell R., Timchalk M. Five years of experience in patients receiving home nutrition support with the implanted reservoir: a comparison with the external catheter. JPEN J Parenter Enteral Nutr.1989;13(5):478-83. DOI: 10.1177/0148607189013005478

106. Kuizon D., Gordon S.M., Dolmatch B.L. Single-lumen subcutaneous ports inserted by interventional radiologists in patients undergoing chemotherapy: incidence of infection and outcome of attempted catheter salvage. Arch Intern Med. 2001;161(3):406-10. DOI: 10.1001/archinte.161.3.406

107. Hickman R.O., Buckner C.D., Clift R.A., Sanders J.E., Stewart P., Thomas E.D. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979;148(6):871-5.

108. Broviac J.W., Cole J.J., Scribner B.H. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136(4):602-6.

109. McGee D.C., Gould M.K. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123-33. DOI: 10.1056/NEJMra011883

110. Cotogni P., Pittiruti M., Barbero C., Monge T., Palmo A., Boggio Bertinet D. Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. JPEN J Parenter Enter Nutr. 2013;37(3):375-83. DOI: 10.1177/0148607112460552

111. Cowl C.T., Weinstock J.V., Al-Jurf A., Ephgrave K., Murray J.A., Dillon K. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters. Clin Nutr. 2000;19(4):237-43. DOI: 10.1054/clnu.2000.0103

112. Verso M., Agnelli G., Kamphuisen P.W., Ageno W., Bazzan M., Lazzaro A., et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med. 2008;3(2):117-22. DOI: 10.1007/s11739-008-0125-3

113. Cadman A., Lawrance J.A., Fitzsimmons L., Spencer-Shaw A., Swindell R. To clot or not to clot? That is the question in central venous catheters. Clin Radiol. 2004;59(4):349-55. DOI: 10.1016/j.crad.2003.11.015

114. O'Grady N.P., Alexander M., Burns L.A., Dellinger E.P., Garland J., Heard S.O., et al. Healthcare infection control practices advisory committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(Suppl. 1):S1-4. DOI: 10.1016/j.ajic.2011.01.003

115. Goode C.J., Titler M., Rakel B., Ones D.S., Kleiber C., Small S., et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res. 1991;40(6):324-30.

116. Capdevila J.A., GavaldJ., Fortea J., Lopez P., Martin M.T., Gomis X., et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheterrelated infection due to Staphylococcus aureus using the antibioticlock technique. Clin Microbiol Infect. 2001;7(4):206-12. DOI: 10.1046/j.1469-0691.2001.00233.x

117. Prevention of catheter-associated bloodstream infections and care of the central venous catheter. Clinical guidelines, 2017 (In Russ.). http://nasci.ru/?id=2889

118. Randolph A.G., Cook D.J., Gonzales C.A., Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomized controlled trials. Br Med J. 1998;316(7136):969-75. DOI: 10.1136/bmj.316.7136.969

119. Shanks R.M., Donegan N.P., Graber M.L., Buckingham S.E., Zegans M.E., Cheung A.L., et al. Heparin stimulates staphylococcus aureus biofilm formation. Infect Immun. 2005;73(8):4596-606. DOI: 10.1128/IAI.73.8.4596-4606.2005

120. Goossens G.A., Jerome M., Janssens C., Peetermans W.E., Fieuws S., Moons P., et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol. 2013;24(7):1892-9. DOI: 10.1093/annonc/mdt114

121. Wouters Y., Causevic E., Klek S., Groenewoud H., Wanten G.J.A. Use of Catheter Lock Solutions in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Individual-Patient Data Meta-Analysis. JPEN J Parenter Enteral Nutr. 2020;44(7):1198-209. DOI: 10.1002/jpen.1761

122. Shah C.B., Wittelmann M.W., Costerton J.W., Par-enteau S., Pelak M., Arsenault R., et al. Antimicrobial activity of a new solution for closing the catheter. An-timicrob Agents Chemother. 2002;46(6):1674-9. DOI: 10.1128/AAC.46.6.1674-1679.2002

123. Tribler S., Brandt C.F., Anne H Petersen A.H., Petersen J.H., Fuglsang K.A., Staun M., et al. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial. Am J Clin Nutr. 2017;106(3):839-48. DOI: 10.3945/ajcn.117.158964

124. Gundogan K., Dave N.J., Griffith D.P., Zhao V.M., McNally T.A., Easley K.A., et al. Ethanol Lock Therapy Markedly Reduces Catheter-Related Blood Stream Infections in Adults Requiring Home Parenteral Nutrition: A Retrospective Study From a Tertiary Medical Center. JPEN J Parenter Enteral Nutr. 2020;44(4):661-7. DOI: 10.1002/jpen.1698

125. Zhao T., Liu H., Han J. Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients:a systematic review and meta-analysis. International Urology and Nephrology. 2018;50(9):1643-52. DOI: 10.1007/s11255-018-1855-4

126. Smith C.E., Curtas S., Werkowitch M., Kleinbeck S.V., Howard L. Home parenteral nutrition: does affiliation with a national support and educational organization improve patient outcomes? JPEN J Parenter Enteral Nutr. 2002;26(3):159-63. DOI: 10.1177/0148607102026003159

127. Stoner N.E., Schiavone P., Kinosian B.P., Pickett-Blakely O., Amoroso V.K., et al. Preparing the Patient for Home Parenteral Nutrition and for a Successful Course of Therapy. Gastroenterol Clin North Am. 2019 Dec;48(4):471-81. DOI: 10.1016/j.gtc.2019.08.002

128. Newton A.F., De Legge M.H. Home initiation of parenteral nutrition. Nutr Clin Pract. 2007;22(1):57-64. DOI: 10.1177/011542650702200157

129. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(1):1SA-138SA.

130. Santarpia L., Pasanisi F., Alfonsi L., Violante G., Tiseo D., Simone G.D., et al. Prevention and treatment of implanted central venous catheter (CVC) — related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr. 2002;21(3):207-11. DOI: 10.1054/clnu.2002.0541

131. Kovacevich D., Corrigan M., Ross V.M., McKeever L., Hall A.M., Braunschweig C. American Society for Parenteral and Enteral Nutrition Guidelines for the Selection and Care of Central Venous Access Devices for Adult Home Parenteral Nutrition Administration. JPEN J Parenter Enteral Nutr. 2019;43(1):15-31. DOI: 10.1002/jpen.1455

132. Rege A.S., Sudan D.L. Autologous gastrointestinal reconstruction: review of the optimal nontransplant surgical options for adults and children with short bowel syndrome. Nutr Clin Pract. 2013;28(1):65-74. DOI: 10.1177/0884533612460405

133. Abu-Elmagd K.M., Armanyous S.R., Fujiki M., Parekh N.R., Osman M., Scalish M., et al. Management of Five Hundred Patients With Gut Failure at a Single Center: Surgical Innovation Versus Transplantation With a Novel Predictive Model. Ann Surg. 2019;270(4):656-74. DOI: 10.1097/SLA.0000000000003523

134. Gondolesi G.E., Doeyo M., Lic C.E., Lobos F., Rubio S., Rumbo C., et al. Results of Surgical and Medical Rehabilitation for Adult Patients With Type III Intestinal Failure in a Comprehensive Unit Today: Building a New Model to Predict Parenteral Nutrition Independency. JPEN J Parenter Enteral Nutr. 2020;44(4):703-13. DOI: 10.1002/jpen.1686

135. Khan F.A., Squires R.H., Litman H.J., Balint J., Carter B.A., Fisher J.G., et al. Predictors of enteral autonomy in children with intestinal failure: a multicenter cohort study. J Pediatr. 2015;167(1):29-34. DOI: 10.1016/j.jpeds.2015.03.040

136. Gondolesi G.E., Doeyo M., Lic C.E., Lobos F., Rubio S., Rumbo C., et al. Results of Surgical and Medical Rehabilitation for Adult Patients With Type III Intestinal Failure in a Comprehensive Unit Today: Building a New Model to Predict Parenteral Nutrition Independency. JPEN J Parenter Enteral Nutr. 2020;44(4):703-13. DOI: 10.1002/jpen.1686

137. Rege A. The Surgical Approach to Short Bowel Syndrome — Autologous Reconstruction versus Transplantation. Viszer-almedizin. 2014;30(3):179-89. DOI: 10.1159/000363589

138. Abu-Elmagd K.M., Armanyous S.R., Fujiki M., Parekh N.R., Osman M., Scalish M., et al. Management of Five Hundred Patients With Gut Failure at a Single Center: Surgical Innovation Versus Transplantation With a Novel Predictive Model. Ann Surg. 2019;270(4):656-74. DOI: 10.1097/SLA.0000000000003523

139. Abu-Elmagd K.M., Costa G., McMichael D., Khanna A., Cruz R.J., et al. Autologous Reconstruction and Visceral Transplantation for Management of Patients With Gut Failure After Bariatric Surgery: 20 Years of Experience. Ann Surg. 2015;262(4):586-601. DOI: 10.1097/SLA.0000000000001440

140. Allan P.J., Stevens P., Abraham A., Paine P., Farrer K., Teubner A., et al. Outcome of intestinal failure after bariatric surgery: experience from a national UK referral centre. Eur J Clin Nutr. 2016;70(7):772-8. DOI: 10.1038/ejcn.2016.37

141. Hornsby-Lewis L., Shike M., Brown P., Klang M., Pearlstone D., Brennan M.F. L-glutamine supplementation in home total parenteral nutrition patients: stability, safety, and effects on intestinal absorption. J Parenter Enter Nutr. 1994;18(3):268-73. DOI: 10.1177/0148607194018003268

142. Kelly D.G., Tappenden K.A., Winkler M.F. Short bowel syndrome: highlights of patient management, quality of life, and survival. JPEN J Parenter Enteral Nutr. 2014;38(4):427-37. DOI: 10.1177/0148607113512678

143. Rodrtguez Iglesias P., DomenechTarreg A.B., Driller C., Mangas Alvarez L., Vila Carbo J.J. Efficacy of the intestinal rehabilitation program in patients with short bowel syndrome. Cir Pediatr. 2019;32(2):74-80.

144. Ramos-Gonzalez G., Kim H.B. Autologous intestinal reconstruction surgery. Semin Pediatr Surg. 2018;27(4):261-6. DOI: 10.1053/j.sempedsurg.2018.08.001

145. Frongia G., Kessler M., Weih S., Nickkholgh A., Mehrabi A., Holland-Cunz S. Comparison of LILT and STEP procedures in children with short bowel syndrome — a systematic review of the literature. J Pediatr Surg. 2013;48(8):1794-805. DOI: 10.1016/j.jpedsurg.2013.05.018

146. Shah A.A., Petrosyan M., Franklin A.L., Chahine A.A., Torres C., Sandler A.D. Autologous intestinal reconstruction: a single institution study of the serial transverse enteroplasty (STEP) and the longitudinal intestinal lengthening and tailoring (LILT). Pediatr Surg Int. 2019;35(6):649-55. DOI: 10.1007/s00383-019-04468-3

147. Jones B.A., Hull M.A., Potanos K.M., Zurakowski D., Fitzgibbons S.C., Ching Y.A., et al. Report of 111 consecutive patients enrolled in the International Serial Transverse Enteroplasty (STEP) Data Registry: a retrospective observational study. J Am Coll Surg. 2013;216(3):438-46. DOI: 10.1016/j.jamcollsurg.2012.12.018

148. Belza C., Wales P.W. Multidisciplinary Management in Pediatric Ultrashort Bowel Syndrome. J Multidiscip llcallhe. 2020;13:9-17. DOI: 10.2147/JMDH.S236130

149. Jones B.A., Hull M.A., Kim H.B. Autologous intestinal reconstruction surgery for intestinal failure management. Curr Opin Organ Transplant. 2010;15(3):341-5. DOI: 10.1097/MOT.0b013e328338c2c0

150. Pakarinen M.P., Kurvinen A., Koivusalo A.I., Iber T., Rintala R.J. Long-term controlled outcomes after autologous intestinal reconstruction surgery in treatment of severe short bowel syndrome. J Pediatr Surg. 2013;48(2):339-44. DOI: 10.1016/j.jpedsurg.2012.11.014

151. Pironi L., Konrad D., Brandt C., Joly F., Wanten G., Agostini F., et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey. Clin Nutr. 2018;37(2):728-38.

152. Chungfat N., Dixler I., Cohran V., Buchman A., Abecassis M., Fryer J. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg. 2007;205(6):755. DOI: 10.1016/j.jamcoll-surg.2007.06.299

153. Vianna R., Fridell J.A., Mangus R., Hollinger E.F., Matiosky A., Tector A.J. Safe inclusion of the entire pancreas as a component of the multivisceral graft. Transplantation. 2008;86(1):114-6. DOI: 10.1097/TP.0b013e318177df76

154. Wu G., Selvaggi G., Nishida S.,Moon J., Island E., Ruiz P., et al. Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation. 2011;91(2):219-24. DOI: 10.1097/TP.0b013e3181ff86ec

155. Abu-Elmagd K.M. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology. 2006;130(2):S132-7. DOI: 10.1053/j.gastro.2005.09.069

156. Iyer K.R., Iverson A.K., DeVoll-Zabrocki A., Buckman S., Horslen S., Langnas A. Pediatric intestinal transplantation--review of current practice. Nutr Clin Pract. 2002;17(6):350-60. DOI: 10.1177/0115426502017006350

157. Fiel M.I., Sauter B., Wu H.S., Rodriguez-Laiz G., Gondolesi G., Iyer K., et al. Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clin Gastroenterol Hepatol. 2008;6(8):926-33. DOI: 10.1016/j.cgh.2008.04.011

158. Nightingal J., Woodward J.M. Guidelines for management of patients with a short bowel.Gut. 2006;55(4):iv1-12. DOI: 10.1136/gut.2006.091108

159. Di Base J.K., Young R.J., Vanderhoof J.A. Intestinal Rheabilitation and the Short Bowel Syndrome: Part 2. Am J Gastrroenterology. 2004;99(9):1823-32. DOI: 10.1111/j.1572-0241.2004.40836.x

160. American Gastroenterological Association. American gastroenterological Association medical position statement: Short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124(4):1105-10. DOI: 10.1053/gast.2003.50139

161. Sudan D., Thompson J., Botha J., Grant W., Antonson D., Raynor S., et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg. 2007;246(4):593-601. DOI: 10.1097/SLA.0b013e318155aa0c

162. Rana S.V., Bhardwaj S.B. Small intestinal bacterial overgrowth. Scand J Gastroenterol. 2008;43(9):1030-7. DOI: 10.1080/00365520801947074